Skip to main content
Home
Canada
Business
Investing
Life
Opinion
World
Politics
Personal Finance
Culture
More
More
Latest in
More
Real Estate
Sports
Drive
Watchlist
For You
Events
Find clarity in the chaos.
Subscribe now and save 70%
Flash Sale
Digital access
Digital + home delivery
TSX
-0.25%
S&P 500
0.12%
DOW
-0.13%
NASDAQ
0.2%
Oil
2.9%
Dollar
-0.15%
Gold
-1.12%
tsx movers:
ARX-T
+21.15%
ENB-T
-1.77%
BTE-T
+3.19%
CNQ-T
+1.22%
Instrument Name
Natera Inc
Instrument Symbol
(NTRA-Q)
Instrument Exchange
NASDAQ
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
Pre Market
Change
Pre Market
Last Update
Pre Market
Price
Volume
Summary
Charts
Dividends
Analysts
Price Report
Financials
Profile
Statistics
Insiders
Natera Inc
13011 McCallen Pass Building A Suite 100
Austin TX 78753 USA
P:
650-980-9190
http://www.natera.com
Sectors & Indices
Sector
Industry
Employees
SIC-8071 Services-Medical Laboratories
Medical Services
Indices Nasdaq Composite
Indices Russell 1000
Indices Russell 3000
Profile
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Key Executives
Name
Title
Michael Brophy
CFO/Chief Accounting Officer
Steven Leonard Chapman
CEO/Co-President/Director
Daniel Rabinowitz
Chief Legal Officer/Secretary
Solomon Moshkevich
President, Divisional
John Fesko
Co-President/Other Executive Officer
More from The Globe
The most oversold and overbought stocks on the TSX
Yesterday
Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO
April 22, 2026
Bullish on Pembina Pipeline Corp.
Monica Rizk
April 21, 2026
trade secrets
How investors should digest the stock market’s ‘sugar high’
April 21, 2026
newsletter
Market Factors: Top picks, sector review for income-heavy utilities sector
April 20, 2026
The most oversold and overbought stocks on the TSX
April 20, 2026
The highest-yielding stocks on the TSX, plus risk data
April 20, 2026
top links
Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility
April 20, 2026